Crossmark

The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation

Crossref DOI link: https://doi.org/10.1186/s13014-019-1327-8

Published Online: 2019-07-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ono, Yuka

Yoshimura, Michio

Hirata, Kimiko

Yamauchi, Chikako

Toi, Masakazu

Suzuki, Eiji

Takada, Masahiro

Hiraoka, Masahiro

Mizowaki, Takashi
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (17ck0106151h0003)
License Information

Text and Data Mining valid from 2019-07-10

Version of Record valid from 2019-07-10
More Information

Article History

Received: 28 February 2019

Accepted: 26 June 2019

First Online: 10 July 2019

Ethics approval and consent to participate

: The study was conducted in accordance with the Declaration of Helsinki, and our Institutional Ethical Review Board approved the work (approval number R0156). Written informed consent was obtained from all patients.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below